文献
J-GLOBAL ID:202202215694184572
整理番号:22A0805140
生物学的製剤から生物類似製品への切り替え:統合健康管理システムからの洞察【JST・京大機械翻訳】
Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System
著者 (9件):
Bhardwaja Bharati
(Clinical Pharmacy Specialist, Kaiser Permanente Colorado, Denver, CO, USA)
,
Bhardwaja Bharati
(Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA)
,
Klocke Shilpa
(Clinical Pharmacy Specialist, Kaiser Permanente Colorado, Denver, CO, USA)
,
Klocke Shilpa
(Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA)
,
Ekinci Ekim
(Clinical Pharmacy Specialist, Kaiser Permanente Colorado, Denver, CO, USA)
,
Jackson Adam
(Clinical Pharmacy Specialist, Kaiser Permanente Colorado, Denver, CO, USA)
,
Kono Scott
(Department of Oncology, University of Colorado Health, Denver, CO, USA)
,
Olson Kari L.
(Clinical Pharmacy Specialist, Kaiser Permanente Colorado, Denver, CO, USA)
,
Olson Kari L.
(Clinical Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA)
資料名:
BioDrugs
(BioDrugs)
巻:
36
号:
1
ページ:
1-11
発行年:
2022年
JST資料番号:
W0641A
ISSN:
1173-8804
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)